Table 2 Pilot study compliance and 12-month primary and secondary outcomes
Treatment (n = 65) | Control (n = 56) | Odds ratio | (95% CI) | |||
|---|---|---|---|---|---|---|
Study compliance | ||||||
Completed >3 sessions, % (n) | 66.2 | (43) | 62.5 | (35) | ||
Completed 6-month survey, % (n) | 60.0 | (39) | 53.6 | (30) | ||
Completed 12-month survey, % (n) | 92.3 | (60) | 85.7 | (48) | ||
Primary outcome: utilizationa | ||||||
>1 ED visit/hospitalization in follow-up year, % (n) | 33.8 | (22) | 46.4 | (26) | 0.53 | (0.24–1.15) |
Secondary outcomes | ||||||
Change of ACT score from baseline, median (range) | 2 | (24) | 2 | (20) | ||
Functional statusb in the last 30 days | ||||||
>2 symptom days/week over 30 days | ||||||
Yes, % (n) | 25.9 | (15) | 28.3 | (13) | 0.87 | (0.36–2.11) |
No, % (n) | 74.1 | (43) | 71.7 | (33) | ||
>2 school days missed/30 days (any reason) | ||||||
Yes, % (n) | 9.6 | (5) | 5.3 | (2) | 1.85 | (0.33–10.34) |
No, % (n) | 90.4 | (47) | 94.7 | (36) | ||
>2 school or work days missed/30 days (asthma) | ||||||
Yes, % (n) | 9.5 | (4) | 0 | (0) | Not calculated | |
No, % (n) | 90.5 | (38) | 100 | (29) | ||
ASRDI at 12 months, mean (sd) | 3.1 | (1.2) | 2.7 | (1.2) | ||
Targeted behaviors, % (n) | ||||||
Among patients reporting controller medication at session 1 | ||||||
Adherent >5 days of the past 7 days, % (n) | 62.1 | (18) | 50 | (5) | 1.62 | (0.38–6.93) |
Among patients reporting rescue inhaler at session 1 | ||||||
Rescue inhaler available >5 days/7 days, % (n) | 54.5 | (24) | 70.4 | (19) | 0.50 | (0.18–1.36) |